drugset / Trial / NCT01182337

A Clinical Trial to Evaluate the Safety, Tolerability and Preliminary Effectiveness of Single Administration Intradiscal rhGDF-5 for the Treatment of Early Stage Lumbar Disc Degeneration

NCT01182337 ↗

Phase 1/2 Completed 31 enrolled DePuy Spine Janssen Korea, Ltd., Korea · collab
RandomizedParallel-groupDouble-blind

Summary

Study to show the safety, tolerability and preliminary effectiveness of Intradiscal rhGDF-5 in subjects with early lumbar disc degeneration

Timeline

Start
2010-06
Primary completion
2014-06
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject RADOTERMIN Protein / enzyme biologic — Other